The board of directors of Venus Medtech (Hangzhou) Inc. announced that Mr. Lim HouSen (Lin Haosheng) has been appointed as the joint chief executive officer of the Company with effect from September 22, 2023. Biographical details of Mr. Lim are set out as follows: Mr. Lim HouSen (Lin Haosheng), aged 49, is the senior vice president of oversea affairs of the Company. Mr. Lim joined the Group in December 2016 as the chief technology officer.

Mr. Lim is primarily responsible for business operations, regulatory approvals, quality control and commercial suitability and sustainability of products of the Group. Mr. Lim served as an executive Director of the Company from November 2018 to January 2023. Mr. Lim has more than 20 years of industry experience.

Prior to joining the Group, Mr. Lim was the managing director and chief technology officer of Transcatheter Technologies GmbH, a medical device company incorporated in Germany, which primarily focuses on heart valve implantation and aortic therapy solutions, from January 2009 to October 2016. From September 2005 to December 2008, Mr. Lim was the founder and served as the chief executive officer of EndoCor Pte. Ltd., a company incorporated in Singapore, which develops minimally invasive heart valve and medical devices in the structural heart space.

From March 2003 to December 2008, Mr. Lim was a managing director in a biomedical company named Embryon Inc., which primarily engages in research and experimental development on biotechnology, life and medical science. Mr. Lim received a bachelor's degree in mechanical engineering from Nanyang Technological University in Singapore in July 1999 and a master's degree of engineering from Nanyang Technological University in Singapore in June 2002.